Alaunos Acquires Velaris in $350 Million Private Placement
Alaunos Therapeutics reported the acquisition of Velaris Therapeutics and a $350 million private placement led by Fairmount. Its shares more than doubled to $2.92.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.